Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2023 | 09-2023 | 07-2023 | 06-2023 | 04-2023 | |
| Operating Expenses | 10,442 | 2,574 | 6,248 | 4,284 | 4,737 |
| Operating Income | -17,436 | -2,574 | -6,248 | -4,284 | -4,737 |
| Interest Expense | 1,159 | 0 | 1,442 | 0 | 1,177 |
| Other Income | -77,459 | 1,788 | 2,970 | 1,575 | 632 |
| Pre-tax Income | -96,054 | -785 | -4,720 | -2,708 | -5,282 |
| Net Income Continuous | -89,130 | -785 | -4,720 | -2,708 | -5,282 |
| Net Income | $-89,130 | $-785 | $-4,720 | $-2,708 | $-5,282 |
| EPS Basic Total Ops | -150.98 | -0.05 | -8.55 | -0.17 | -9.30 |
| EPS Basic Continuous Ops | -118.45 | -0.25 | -6.73 | -0.86 | -7.61 |
| EPS Diluted Total Ops | -150.98 | -0.05 | -8.55 | -0.17 | -9.30 |
| EPS Diluted Continuous Ops | -118.45 | -0.25 | -6.73 | -0.86 | -7.61 |
| EBITDA(a) | $-10,393 | $-2,574 | $-6,205 | $-4,284 | $-4,700 |